Danvers, MA, United States of America

Biochemics, Inc.

Calculating rank
USPTO Granted Patents = 12

% Expired Patents = 75.0



Trademarks = 3

Forward Citations = 151

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Stephen G Carter (12 out of 12 patents)

silverMedal Zhen Zhu (11 out of 15 patents)

bronzeMedal Kanu Patel (10 out of 12 patents)

4.  John J Masiz (8 out of 15 patents)

5.  Diane L Kozwich (5 out of 5 patents)

6.  Laura Stephens (3 out of 3 patents)

7.  David H Donabedian (2 out of 4 patents)

8.  Lixin Qiao (1 out of 40 patents)

9.  Gyula Varadi (1 out of 2 patents)

10.  Zhen Zhu (0 patent)


12 patents:

Company Overview
Biochemics, Inc. is a specialized organization based in Danvers, MA, focusing on the development and manufacturing of innovative biopharmaceuticals. The company is dedicated to advancing therapeutic solutions through its expertise in biochemistry and molecular biology. Biochemics engages in research that spans various domains, including drug formulation and delivery systems, aiming to enhance treatment efficacy and patient outcomes. Their commitment to scientific excellence positions them as a key player in the biopharmaceutical landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

12 Patents

#11 in Danvers, MA

#1,549 in Massachusetts

#25,589 in US

#48,235 in the World

Danvers, MA (US)
Danvers, MA, United States of America
Forward Citations = 151

9 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biochemics, Inc.. Retrieved from https://idiyas.com/company/biochemics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…